This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
SIRT7 regulates dosage compensation and safeguards the female X chromosome.
Nature · 2026
Latest funding
- $1,113,075
Functional role of epigenetic reprogramming for oocyte development
CIHR · 2025 · Nominated PI
- $100,000
Functional role of epigenetic reprogramming for oocyte development
CIHR · 2025 · Nominated PI
1 publications.
SIRT7 regulates dosage compensation and safeguards the female X chromosome.
Simonet NG, Thackray JK, Kesner B, Guitart-Solanes A, Serra F, Espinosa-Alcantud M, Lappala A, Marín-Gual L, Marín-García C, Weissbein U, Castelló-García J, Bauer M, Wang D, Rovirosa L, Tischfield J, Serrano L, Payer B, Ruiz-Herrera A, Vazquez BN, Javierre BM, Vaquero A, Lee JT
Functional role of epigenetic reprogramming for oocyte development
Principal investigators: Payer, Bernhard
Keywords: Epigenetics; Germ Cells; In Vitro Gametes; In Vitro Oogenesis; Meiosis; Ovarian Organoids; Pluripotency; Reprogramming; X-Chromosome Inactivation
Functional role of epigenetic reprogramming for oocyte development
Principal investigators: Payer, Bernhard
Keywords: Epigenetics; Germ Cells; In Vitro Gametes; In Vitro Oogenesis; Meiosis; Ovarian Organoids; Pluripotency; Reprogramming; X-Chromosome Inactivation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.